Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied the requirements for courses comprising at least
-
) General eligibility requirement You meet the general eligibility requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree
-
clinical psychiatry and neurology, as well as in studying immune cell-cell interactions that are hypothesized to underpin autoimmune encephalitis development. The main part of the project will concern basic
-
requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied the requirements for courses comprising at least
-
/advanced/master qualification (i.e. master degree), or have satisfied the requirements for courses comprising at least 240 credits of which at least 60 credits were awarded in the advanced/second-cycle
-
general eligibility requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied the requirements
-
Associate Professor Ida Nilsson (main supervisor, https://ki.se/en/people/ida-nilsson).Asa doctoral student you are expected to take a leading role in your research education process under the supervison
-
working hypotheses as appropriate Develop research questions, analyse detailed and complex qualitative and/or quantitative data from a variety of sources, and contribute original ideas for new research
-
You meet the general eligibility requirement for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied
-
to PhD- and master students - with several different PI´s collaborating on many research topics within aging. Research interests are biological aging, frailty, genetics of dementia, polypharmacy in the old